In line with these oncogenic roles of SHOC2 in human cancers, we recently showed that Shoc2 deletion in the KrasG12D pancreatic tumor model significantly inhibited pancreas growth and progression of murine pancreatic intraepithelial neoplasms (mPanINs) [20]. The gene discussed is SHOC2; the disease is cancer.